Navigation Links
Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
Date:6/29/2009

ROCHESTER, Minn., June 29 /PRNewswire-USNewswire/ -- Pioneering therapeutic trials to investigate the effectiveness of deep brain stimulation (DBS) in hard-to-treat depression, obsessive-compulsive disorder (OCD) and Tourette's syndrome are underway at multiple medical centers around the world, according to a review in the June 2009 issue of Mayo Clinic Proceedings. "Deep brain stimulation has long been seen as valuable for controlling movement disorders," according to the review, written by Susannah Tye, Ph.D., Mark Frye, M.D., from the Mayo Clinic Department of Psychiatry and Psychology, and Kendall Lee, M.D., Ph.D., Mayo Clinic Department of Neurosurgery. "It now is being investigated for hard-to-treat psychiatric disorders," according to the authors.

"Early results indicate the effect on depression and obsessive compulsive disorder is beneficial, but the therapy needs further study," Dr. Lee says. The potential for this breakthrough treatment is enormous in reducing the toll of mental illness on patients, their families and society, according to the review.

Unlike electroshock therapy (ECT), which stimulates the entire brain, DBS stimulates specific parts of the brain. DBS is thought to be functionally equivalent to creating a lesion on the brain, but with the advantage of being adjustable and reversible.

"It is like implanting a pacemaker for the brain," says Dr. Lee. The patient is awake during deep brain stimulat
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
2. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
3. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
4. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
5. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
6. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
7. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
8. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
9. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
10. Clinical and Histopathological Results Using Pollogens TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
11. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...RNewswire/ -- Patients reported C1-esterase inhibi...n treating acute swelling attacks at any body loca... according to data presented today at the 2009 Ame...(ACAAI) Annual Meeting. The results come from a se...el with the ongoing, prospective, open label I nt...
(Date:11/7/2009)...RNewswire/ -- Most patients with hereditary angioe...oncoming HAE attack giving the patients sufficient...dity associated with that attack, according to sur...College of Allergy, Asthma & Immunology (ACAAI...ch as fatigue and nausea, which occur frequently b...
(Date:11/6/2009)...wswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DD... and nine months ended September 30, 2009. ,,...EO, said, "We continue to advance discussions rela.... Several potential partners have committed signif...sources as they evaluate the potential commercial ...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Scientists closer to making implantable bone material thanks to new research 9358 1Scientists closer to making implantable bone material thanks to new research 9358 2Accuray Announces CyberKnife Access Remote Service Product 52715 1Accuray Announces CyberKnife Access Remote Service Product 52715 2Accuray Announces CyberKnife Access Remote Service Product 52715 3Accuray Announces CyberKnife Access Remote Service Product 52715 4SEIU Security Officers Who Protect Kaiser Permanente Hospitals Nationwide Vote Overwhelmingly to Ratify First Ever Union Contract 52712 1SEIU Security Officers Who Protect Kaiser Permanente Hospitals Nationwide Vote Overwhelmingly to Ratify First Ever Union Contract 52712 2
...and, September 24 Arpida,Ltd. (SWX: ARPN) today a...II ,intravenous-to-oral, switch trial with oral ic...Structure Infections (cSSSI)., The trial was desi...tudy. Patients suffering from cSSSI received intra...reatment and were then randomised to either,contin...
...as Completed Recruitment of Patients in the Phase ...ory Follicular NHL, COPENHAGEN, September 23 Gen...d recruitment of patients in the,pivotal Phase III...refractory follicular non-Hodgkin,s lymphoma (NHL)...000 mg dose level of ofatumumab have been,recruite...
Other Medicine Technology:Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 2Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim 3Recruitment Completed in Ofatumumab NHL Pivotal Study 2Recruitment Completed in Ofatumumab NHL Pivotal Study 3
(Date:11/7/2009)...USTON, Nov. 7 Members o...duce an emergency resolution rescinding the AMA,s ...icians that they are responsible to their PATIENTS...kes, Director of Policy for the Association of Ame...ine, a coalition of other medical groups. ,, "...
(Date:11/7/2009)...SHINGTON, Nov. 7 With t...antichoice extremists are holding the entire bill ... are demanding that the bill go far beyond the sta...orporated into the original bill. In an outrageou...y Saturday afternoon, antichoice Democrats are dem...
(Date:11/7/2009)...Brown: "Faithful Catholics have a responsibility t...gotiate the status quo." ,, WASHINGTON, Nov. ...ue president Judie Brown released the following st...ll support Speaker Nancy Pelosi,s Affordable Healt...endment preserving the status quo for abortion is ...
(Date:11/7/2009)...SHINGTON, Nov. 7 The U....f Representatives to vote for the Stupak-Ellsworth...tupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-S...law on abortion funding and conscience protections...R. 3962)," they said. ,, The letter was signed ...
(Date:11/7/2009)...SHINGTON, Nov. 7 Speake... availability this afternoon following a Democrati...Caucus Room. Below are the Speaker,s opening rema...it was a great occasion for us to receive the Pres...l be making history with our vote and making progr...
Breaking Medicine News(10 mins):Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2
...er Prevention, Treatment and Care Services for Peo...s and Malaria , , WASHINGTON, March 11 Late ye...he Omnibus Appropriations bill for fiscal year 200...sis and Malaria. , , (Logo: http://www.newscom....
...ancer cells and their frequent divisions have thei...y than healthy cells. Their metabolism runs at ful...ts, particularly iron. However, high levels of iro... what are called iron storage proteins. , Collabo...
...rch 11 /PRNewswire-USNewswire/ -- Orthopaedic su... the Board of Councilors (BOC) of the American ...9 Annual Meeting at the Venetian Sands Expo Center...and will work tirelessly to ensure that our states...
... Government Agencies Can Purchase ATI,s Tech...n the GSA Online Ordering System , ...erican TeleCare, Inc. (ATI), leader in the develop...ew contracts with the Veterans Health Administrati...
...ears of Personal Experience with Complex Rehab Nee... a complex rehab specialist, has joined Alliance ... fastest growing accredited complex rehab companie...ons for pediatrics and adults with severe physical...
...s a D 14 States Improve Grades; 12 Fall Backwards ...GTON, March 11 The National Alliances on Ment...ading the States , assessing the nation,s public m...rnewswire.com/mnr/nami/37177/ , , Fourteen state...
Other Medicine News:Health News:Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund 2Health News:David Teuscher, MD, Elected Secretary of Academy Board of Councilors 2Health News:American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration 2Health News:American TeleCare, Inc. (ATI) Renews Agreements for its Telehealth Solutions with the Veterans Health Administration 3Health News:Rehab Specialist, Michael Fisher, Joins Fast - Growing Alliance Seating & Mobility in North Carolina 2Health News:Video: New Report Card: Nation's Mental Health Care System 2Health News:Video: New Report Card: Nation's Mental Health Care System 3
Vac-Man® Laboratory Vacuum Manifold, 20-sample capacity
... new QIAvac 24 Plus vacuum manifold allows process...ing the tedious loading and unloading of spin colu...24 Plus offers: Time savings rapid vacuum-dri... DNA, PCR products, and RNA Convenience minim...
... TurboVap Concentration Workstations from Caliper ..., Rotary, Vacuum-Style and Nitrogen Blow-Down Evap... technology has received enormous acclaim with ove... ...
... BioVacTM96 Vacuum Manifold system has been design...xtraction kits. The kit can handle 96 samples (Pla...y for effective extraction and purification. While...o a spin column, the BioVac 96 Vacuum Manifold use...
Medicine Products: